Archives of Medical Science (Nov 2022)
2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy
- Maciej Banach,
- Zeljko Reiner,
- Arrigo F.G. Cicero,
- Pierre Sabouret,
- Margus Viigimaa,
- Amirhossein Sahebkar,
- Arman Postadzhiyan,
- Dan Gaita,
- Daniel Pella,
- Peter E. Penson,
- International Lipid Expert Panel (ILEP)
Affiliations
- Maciej Banach
- ORCiD
- Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland
- Zeljko Reiner
- ORCiD
- Department of Internal Medicine, University Hospital Centre Zagreb, Zagreb, Croatia
- Arrigo F.G. Cicero
- ORCiD
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
- Pierre Sabouret
- ORCiD
- Heart Institute and Action Group, Pitié-Salpétrière, Sorbonne University Paris, Paris, France
- Margus Viigimaa
- ORCiD
- Department of Health Technologies, Tallinn University of Technology, Tallinn, Estonia
- Amirhossein Sahebkar
- ORCiD
- Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
- Arman Postadzhiyan
- ORCiD
- Department of General Medicine, Emergency University Hospital "St. Anna", Medical University of Sofia, Sofia, Bulgaria
- Dan Gaita
- ORCiD
- Universitatea de Medicina si Farmacie Victor Babes din Timisoara, Romania
- Daniel Pella
- ORCiD
- 2nd Department of Cardiology of the East Slovak Institute of Cardiovascular Disease and Faculty of Medicine PJ Safarik University, Kosice, Slovak Republic
- Peter E. Penson
- ORCiD
- Clinical Pharmacy and Therapeutics Research Group, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK
- International Lipid Expert Panel (ILEP)
- DOI
- https://doi.org/10.5114/aoms/156147
- Journal volume & issue
-
Vol. 18,
no. 6
pp. 1429 – 1434
Abstract
No abstracts available.
